VIRX
Viracta Therapeutics, Inc. Common Stock
VIRX
VIRX
Delisted
VIRX was delisted on the 3rd of February, 2025.
56 hedge funds and large institutions have $23.5M invested in Viracta Therapeutics, Inc. Common Stock in 2016 Q2 according to their latest regulatory filings, with 6 funds opening new positions, 9 increasing their positions, 15 reducing their positions, and 6 closing their positions.
New
Increased
Maintained
Reduced
Closed
more call options, than puts
Call options by funds: $ | Put options by funds: $
more funds holding
Funds holding: →
more first-time investments, than exits
New positions opened: | Existing positions closed:
less capital invested
Capital invested by funds: $ → $
40% less repeat investments, than reductions
Existing positions increased: 9 | Existing positions reduced: 15
Holders
56
Holding in Top 10
–
Calls
$186K
Puts
$87K
Top Buyers
| 1 | +$822K | |
| 2 | +$111K | |
| 3 | +$15K | |
| 4 |
TSS
Two Sigma Securities
New York
|
+$12K |
| 5 |
Vanguard Group
Malvern,
Pennsylvania
|
+$11.6K |
Top Sellers
| 1 | -$1.94M | |
| 2 | -$68.8K | |
| 3 | -$41.6K | |
| 4 |
Susquehanna International Group
Bala Cynwyd,
Pennsylvania
|
-$32.8K |
| 5 |
DCM
Driehaus Capital Management
Chicago,
Illinois
|
-$18.6K |